Division of Health and Nutrition Survey and Analysis, Bureau of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
Bureau of Chronic Disease Prevention and Control, Korea Disease Control and Prevention Agency, Cheongju, Korea.
Epidemiol Health. 2023;45:e2023014. doi: 10.4178/epih.e2023014. Epub 2023 Feb 1.
This study aimed to analyze the changes in chronic disease management indicators, including hypertension, diabetes mellitus, and hypercholesteremia, from 2010-2020 and before (2019) and during (2020) the coronavirus disease 2019 (COVID-19) pandemic.
This study included 58,504 individuals aged ≥30 years who participated in the Korea National Health and Nutrition Examination Survey 2010-2020. Trends in the prevalence, awareness, treatment, and control of chronic diseases and the difference in those between before and during the COVID-19 pandemic were analyzed using the SAS program PROC SURVEYREG.
From 2010-2020, the awareness, treatment, and control in adults aged ≥30 years for hypertension and hypercholesterolemia continuously improved, whereas no significant change in the management indicators of diabetes mellitus was observed. The prevalence of hypertension, diabetes mellitus, and hypercholesterolemia in men increased from before to during the COVID- 19 pandemic. However, there was no significant change in the management indicators of hypertension and diabetes mellitus in men and women, and the awareness, treatment, and control rates for hypercholesterolemia increased by 5.5%p, 6.9%p, and 4.1%p respectively.
In 2020, the first year of the COVID-19 pandemic, the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia increased, but the management indicators of the chronic diseases did not significantly deteriorate. Considering the ongoing COVID-19 pandemic, it is necessary to monitor changes in chronic disease management indicators and to develop efficient and accessible chronic disease prevention and management programs.
本研究旨在分析 2010-2020 年以及新冠疫情期间(2020 年)慢性疾病管理指标(包括高血压、糖尿病和高胆固醇血症)的变化情况。
本研究纳入了参加 2010-2020 年韩国国家健康与营养调查的 58504 名年龄≥30 岁的个体。使用 SAS 程序 PROC SURVEYREG 分析慢性疾病的患病率、知晓率、治疗率和控制率的趋势,以及新冠疫情前后的差异。
2010-2020 年,≥30 岁成年人的高血压和高胆固醇血症知晓率、治疗率和控制率持续提高,而糖尿病管理指标无显著变化。男性高血压、糖尿病和高胆固醇血症的患病率从新冠疫情前到期间有所增加。然而,男性和女性的高血压和糖尿病管理指标没有显著变化,高胆固醇血症的知晓率、治疗率和控制率分别提高了 5.5%p、6.9%p 和 4.1%p。
2020 年,即新冠疫情的第一年,高血压、糖尿病和高胆固醇血症的患病率有所增加,但慢性疾病的管理指标并未显著恶化。考虑到新冠疫情的持续存在,有必要监测慢性疾病管理指标的变化,并制定高效、可及的慢性疾病预防和管理计划。